Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Effects Toxics”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT02119091
What this trial is testing

Race Difference Moxifloxacin-induced QT Prolongation Between Healthy Chinese and Caucasian Volunteers

Who this might be right for
Cardiac Toxicity
Haiyan Li 80
Not applicableStudy completedNCT04174469
What this trial is testing

Ivermectin Neurotoxicity and ABCB1 Gene Mutations

Who this might be right for
DNA Sequencing
University Hospital, Montpellier 3
Testing effectiveness (Phase 2)UnknownNCT00003251
What this trial is testing

Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganHead and Neck CancerRadiation Toxicity
University of Illinois at Chicago 46
Not applicableNot Yet RecruitingNCT07841951
What this trial is testing

Two Bupivacaine Concentrations for Rectus Intercostal Fascial Plane Block After Laparoscopic Cholecystectomy

Who this might be right for
Postoperative PainAcute PainCholelithiasis+1 more
Medipol University 90
Testing effectiveness (Phase 2)Study completedNCT04799639
What this trial is testing

Efficacy and Toxicity of Paclitaxel, Cisplatin Combined With Sindilimab in NACT for Locally Advanced Cervical Cancer

Who this might be right for
Cervical CancerChemotherapy EffectProgrammed Cell Death 1 Receptor / Antagonists & Inhibitors+1 more
Sun Yat-sen University 47
Not applicableStudy completedNCT00577798
What this trial is testing

Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin

Who this might be right for
Cardiac ToxicityChemotherapeutic Agent ToxicityLymphoma
University of Nebraska 10
Testing effectiveness (Phase 2)Looking for participantsNCT03480971
What this trial is testing

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

Who this might be right for
MucositisNephrotoxicityOtotoxicity
Matrix Biomed, Inc. 120
Early research (Phase 1)Study completedNCT00812071
What this trial is testing

Phase 1B Study of RiVax, a Vaccine to Prevent the Toxic Effects of Ricin

Who this might be right for
Healthy
University of Texas Southwestern Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT04737265
What this trial is testing

Pilot Study of an NTproBNP Guided Strategy of Cardioprotection

Who this might be right for
CardiotoxicityToxicity Due to ChemotherapyBreast Cancer+3 more
Abramson Cancer Center at Penn Medicine 108
Large-scale testing (Phase 3)Study completedNCT00556712
What this trial is testing

Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 889
Large-scale testing (Phase 3)UnknownNCT03061058
What this trial is testing

Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGC

Who this might be right for
Stomach NeoplasmsChemotherapy EffectChemotherapeutic Toxicity
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 240
Not applicableUnknownNCT04027478
What this trial is testing

Can Fasting Decrease the Side Effects of Chemotherapy?

Who this might be right for
Chemotherapy EffectChemotherapeutic ToxicityFasting
Sutter Health 39
Not applicableStudy completedNCT04694794
What this trial is testing

Diminish Chemotherapy Related Side Effects Through Patient Education

Who this might be right for
Chemotherapeutic ToxicityChemotherapeutic Agent ToxicityChemotherapy Effect
Milton S. Hershey Medical Center 36
Testing effectiveness (Phase 2)Study completedNCT00436566
What this trial is testing

Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery

Who this might be right for
Breast CancerCardiac Toxicity
Mayo Clinic 122
Not applicableWithdrawnNCT00834496
What this trial is testing

Switching From One Type of Anti-rejection Drug (Tacrolimus or Cyclosporine) to Another (Sirolimus) Approximately 90-180 Days After Liver Transplantation

Who this might be right for
Side Effects of Calcineurin InhibitorsRenal ToxicityHepatic Fibrosis on Biopsy+2 more
Thomas Jefferson University
Not applicableUnknownNCT04253288
What this trial is testing

Prospective Registration of mOrbidity and Mortality, individUal radioSensitivity and Radiation Technique (PROUST)

Who this might be right for
Radiotherapy
Assistance Publique - Hôpitaux de Paris 300
Not applicableStudy completedNCT03787966
What this trial is testing

Attenuating Cancer Treatment-related Toxicity in Oncology Patients With a Tailored Physical Exercise Program

Who this might be right for
Breast Neoplasms
Universidad de Granada 100
Early research (Phase 1)Study completedNCT00005796
What this trial is testing

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ
Indiana University 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05722288
What this trial is testing

Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers

Who this might be right for
Localized Prostate CarcinomaLocally Advanced Cervical CarcinomaLocally Advanced Rectal Carcinoma+15 more
City of Hope Medical Center 49
Post-approval studies (Phase 4)Study completedNCT01013103
What this trial is testing

Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk Patients

Who this might be right for
Coronary Artery DiseaseHMG-CoA Reductase Inhibitor ToxicityAtherosclerosis+2 more
Hippocration General Hospital 72
Next Page